There were an estimated 527,600 new cervical cancer cases and 265,700 deaths from cervical cancer worldwide in 2012 (Torre et al., 2015) . Until recently the primary method for cervical screening was based on the Papanicolaou test (Pap test). The Pap test requires cells to be scraped from the cervix, fixed to a glass slide, stained and reviewed by a trained cytologist. Cellular abnormalities are identified by the cytologist based on cellular morphology and staining characteristics and classified according to the degree of dysplasia (Low grade or High grade). The advantage of the Pap test is that it is a non-invasive and widely accepted screening based test with a high specificity of 95-98% and a sensitivity of 74-96% ( Kitchener et al., 2011). The variability in the rates of sensitivity can be due to sampling technique; the subjectivity of the cytology based screening and can result in a high rate of gynaecological referral and patient recall which adds to cost and patient stress. Persistent infection with high risk human papillomavirus (HPV), such as HPV types 16, 18, is accepted as the major cause of cervical pre-cancer and cancer (Walboomers et al., 1999)(Ronco et al., 2010). HPV DNA testing has a higher sensitivity (>95%) but lower specificity (~ 84%) than the Pap test (Cuzick et al., 2013) and these tests are expensive, time-consuming and provide no information on cervical cytopathology. Current gold standard methods for detection of cervical cancer and precancer are therefore limited and there is an unmet clinical need for new objective screening or diagnostic tests. Optical spectroscopic techniques, such as Raman or infrared spectroscopy, are label-free, non-invasive and have several advantages over traditional approaches, including objectivity, speed and cost. These methods can provide quantitative information based on the spectroscopic signature of the biochemical components of the sample allowing diagnosis to be based on biochemical changes rather than on morphological changes. The focus of the present study is on Raman spectroscopy which is based on inelastic light scattering. The coupling of the light generates vibrations within the material and these vibrations are characteristic of the
chemical structure, the energy of the scattered light is reduced by an amount equal to the vibrational energy and from this a rapid, label free, non-destructive measurement of the complete biochemical fingerprint of a biological sample can be obtained. Over the past 15 years, the potential of Raman spectroscopy together with multivariate statistical analysis has been demonstrated for the detection of a variety of cancers, including cervical cancer (Diem et al., 2013) In initial infrared spectroscopy studies on cervical cytopathology samples (González-Solís et al., 2014) (González-Solís et al., 2013) (Wong et al., 1991) , spectra were recorded from cell pellets rather than from single cells and the presence of metaplastic cells, endocervical columnar cells, polymorphs, blood, cervical mucus and debris were all identified as confounding factors (Wong et al, 2002) (Chiriboga et al., 1998) (Cohenford et al., 1997) (Diem et al., 2002) (Romeo et al., 2003) (Wood et al., 1998) .
Recent studies by (Ramos et al., 2016) and (Bonnier et al., 2014) addressed the variability in Raman spectra from cervical smear samples and reported a new method to clear blood residue contamination before Raman spectroscopy based on pre-treatment of the slides with hydrogen peroxide. This method significantly minimised variability and resulted in the collection of highly reproducible data and was employed in this study to reduce variability based on the presence of blood residue. Physiological factors such as hormonal changes during the menstrual cycle or during menopause may also be potential sources of variability in the normal cervix.
The cellular make up of an individual woman's smear is dependent on which day during the menstrual cycle the sample was taken. Days 1-4 are classed as the menstruation phase of the cycle when bleeding will occur and smear samples are generally not taken during this phase.
Days 5-13 are classified as the proliferative phase. During this phase oestrogen levels reach their peak resulting in complete maturation of the squamous epithelium and the cervical smear will present with a higher ratio of superficial cells to intermediate cells. Days 14-28 are classified as the secretory phase where progesterone production reaches its peak and prevents complete maturation of the epithelium. The cervical smear will present with a higher ratio of intermediate cells to superficial cells. During menopause, levels of both oestrogen and progesterone will drop dramatically and there is a gradual arrest of the maturation of the squamous epithelium. This results in the loss of superficial and intermediate cells leading to the final atrophic stage where the squamous epithelium is composed entirely of parabasal cells.
The use of hormone based contraceptives (HC) will affect the natural hormone mediated maturation process of the cervical epithelium. A study by (Romeo et al., 1998) used infrared spectroscopy to investigate hormonal influences on cervical cells throughout the menstrual cycle and showed spectral changes such as increases in the 1200-1000 cm -1 region due to glycogen increases around ovulation (mid cycle). Cervical cells from women on HC did not show the same degree of spectral changes as cells from women not on HC. Despite the variability throughout the menstrual cycle, principal component analysis (PCA) showed good discrimination between high grade dysplasia and normal samples collected at different phases of the menstrual cycle.
A more recent study by (Kanter et al.,2009 ) has shown that hormonal differences due to the menstrual cycle can influence the Raman spectra acquired from the cervix in vivo.
Spectra were divided into four groups, pre-menopausal proliferative phase (days 1-14), premenopausal secretory phase (day 15-28+), peri-menopausal and post-menopausal. Spectral differences were mainly observed at 1250, 1300 and 1320 cm -1 , most likely due to changes in the proteins collagen and elastin (Movasaghi et al.,2007) . Incorporating hormonal status into their dysplasia classification algorithm increased the classification accuracy from 88% to 94%.
The main objective of our study was to investigate hormone associated changes in the Raman spectra of cytologically negative ThinPrep cervical smear samples related to; (1) the menstrual cycle, (2) the onset of menopause and (3) the use of hormone based contraceptives.
A further objective was to determine if any changes observed would interfere with the ability to discriminate normal and high grade dyskaryotic cervical smear samples caused by HPV infection. A slide was prepared for each sample using a ThinPrep 2000 processor (Hologic Inc;
Marlborough, MA 01752). The Thin Prep processor starts by homogenizing the sample by spinning the filter, creating shear forces in the fluid that are strong enough to disaggregate randomly joined material, break up blood, mucus and non-diagnostic debris. The cells are then collected onto the membrane of the filter and transferred onto a glass slide to create a circular monolayer deposit of cells 20mm in diameter and a few microns in thickness. The slide is then ejected automatically into a fixative bath of 95% ethanol.
The presence of blood residues on ThinPrep slides is a limiting factor that needs to be removed in order to collect data with minimal variability. Therefore the slides were treated with a 30% solution of H2O2 at room temperature for 3 minutes. The slides were then placed into a 70% solution of industrial methylated spirits (IMS) for 3 minutes followed by multiple dips into 100% IMS to remove any remaining cellular debris and H2O2. The slide was then air dried. (16,18,31,33.35,39,45,51,52,56,58,59,66 and 68) . Fluorescent oligonucleotides are then added which can bind to the sequences within these primers during the PCR. The detection of these fluorescent oligonucleotides will give either a positive or negative result.
Raman Microspectroscopy
Raman studies were performed using a Horiba Jobin Yvon XploRA system (Villeneuve d'Ascq, France) which incorporates the Olympus microscope Bx41. As source, a 532 nm laser of ~12 mW power was focused onto the sample using a 100X objective (MPlan, Olympus, NA = 0.9) giving a spot size of 1-2 µm. The confocal hole was set at 100µm for all measurements, the specified settings for confocal operation. The system was pre-calibrated to the 520.7cm -1 spectral line for silicon. The 1200 lines per mm grating was used. The backscattered light was measured using an air cooled CCD detector (Andor, 1024-256 pixels). The spectrometer was controlled by Labspec V5.0 software. For each cell, one spectrum was recorded from the nucleus for 2 accumulations of 30 seconds in the spectral range of 400-1800cm -1 . Spectra were recorded only from the cell nucleus as these have been found to be more reproducible and consistent than spectra from the cell cytoplasm. On average 30 cells were recorded from each sample (superficial and intermediate cells)
. The x,y co-ordinates of each cell was recorded on the Raman microscope. After Raman acquisition was complete and following Pap staining, each cell could be re-visited and assigned as superficial or intermediate. The 15 high grade dyskaryotic smears were screened for HSIL cells and spectra recorded accordingly.
Data Pre-Processing and Analysis
Data was normalised and analysed using Matlab software (Mathworks) and specific scripts developed and adapted for uploading of the spectra and their pre-processing, including smoothing (Savitzky-Golay K=5, K=13), baseline correction (Rubberband) and vector
normalization. An in house method for glass removal based on non-negativity constrained least squares was used to remove the spectral features of glass . The algorithm weights the values of glass as well as cell components in the acquired spectra from the cell and further subtracts the glass from the cell spectra applying non-negative constraints.
Classification methods find mathematical models that are able to recognize the membership of each sample to its appropriate class on the basis of a set of measurements. When the classification model has been calibrated, the membership of unknown samples to one of the defined classes can be predicted. Although PCA-LDA is the standard method used to maximise the variations in the X direction, PLS-DA by rotating both the X and Y axes allows even small variations to be captured. This was necessary to identify the normal biochemical changes associated with the menstrual cycle. Partial Least Squares Discriminant Analysis (PLS-DA) was used to build classification models in this study together with leave-one patient-out crossvalidation. PLS-DA analysis was performed using the PLS toolbox (Eigenvector Research) in the Matlab (Mathworks Inc.) environment.
From the data provided by the patient about their last menstrual period and the day on which the sample was taken, the day of the menstrual cycle the smear was taken was calculated. It was assumed that each patient follows the standard 28 day cycle. Samples were only available from days 7-24 of the cycle. Figure 3 .1(C). A lack of cellular material, mucus and cellular debris can be observed which caused difficulties in recording good quality spectra. Figure 3 .2(A) shows the mean Raman spectra of cells from days 7 to 24 of the menstrual cycle. Increases in the Amide I (1640-1650 cm -1 )(see Table 1 ),
Phenylalanine and Tyrosine (1605-1610 cm -1 ) and glycogen (480 cm -1 ) bands over time were observed. The latent variables (LV) scores scatter plot Figure 3.2(B) shows reasonable separation between the proliferative phase (blue) and the secretory phase (red). Some overlapping is observed which is most likely due to the fact that each woman will differ slightly between the days of the menstrual cycle and the levels of oestrogen and progesterone present.
The LV1 loadings shown in Figure 3 .2(C) highlight areas similar to those highlighted in the mean Raman spectra Figure 3 .2(A). The discrimination is mainly based on glycogen (480, 937, 1381, 1458 cm -1 ) which is more present in the secretory samples (red) due to the higher levels of progesterone which promotes sub nuclear glycogen accumulation (Nair et al., 2010) and proteins (CH2 def, 1450 cm -1 ) and Amide I (1669 cm -1 ) which are higher in samples collected from the proliferative phase of the cycle. The prediction plot from the PLS-DA model Figure   3 .2(D) shows reasonably good classification of menstrual cycle phase (proliferative phase or secretory phase) with sensitivity of 83% and specificity of 86%. obscure the little cellular material that is present on the slide and make it very difficult to obtain good spectra hence the number of spectra recorded is severely reduced and it is difficult to draw any firm conclusions. Figure 3 .3(A) shows the mean and standard deviation spectra of the 22 postmenopausal cells recorded. Figure 3 .3(B) shows good discrimination between the two sample types. The loadings shown in Figure 3 .3(C) shows that the discrimination is based on glycogen (852, 1106, 1138 cm -1 ) and nucleic acids (781 cm -1 ) proteins (1450 cm -1 ) and
Amide I (1669 cm -1 ). Figure 3 .3(D) shows the PLS-DA prediction plot which has a sensitivity of 100% and specificity of 95%.
Atrophic samples were not available as part of this study. No firm conclusions can be drawn from this data set except that postmenopausal samples can represent a problem for Raman based screening based on their Pap smear presentation due to mucus, cellular debris and lack of cellular material. Figure 3 .5(B) shows the mean spectra from negative samples from days 7-21 of the menstrual cycle and spectra recorded from HSIL cells.
The LV scores scatterplot in Figure 3 .5(C) shows that HSIL cells separate well from normal cells on the first LV. This shows that regardless of when a sample is taken during day 7-21 of the menstrual cycle, HSIL cells can still be effectively discriminated from cytology negative cells using Raman spectroscopy. Spectral changes due to the hormonal influence of oestrogen and progesterone seem to be less than the spectral changes due to the biochemical changes in the dyskaryotic cells. The loadings from LV1 in Figure 3 .5(D) show that glycogen (495, 1080, 1120, 1380, 1458 cm -1 ), nucleic acids (780 and 1487 cm -1 ), Amide III and Amide I proteins (1239 cm -1 and 1669 cm -1 respectively) and tryptophan and phenylalanine (1605 cm -1 ) mainly contribute towards the discrimination between normal and HSIL cells. As the HSIL cells are a result of a high risk HPV infection, the biochemical difference in glycogen, proteins and nucleic acids can be attributed to the downstream effects of the HPV infection. The predictions plot 
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HC positive samples vs High Grade Dyskaryosis
It is important to determine if the use of HC will also affect the ability of Raman spectroscopy to discriminate normal HC positive cells from HSIL cells. Figure 3 .6(A) shows the mean Raman spectra of HC positive negative samples and spectra from HSIL cells. The LV scores scatterplot in Figure 3 .6(B) shows that spectra from HC positive samples separate from spectra from HSIL cells from high grade dyskaryotic samples on the first LV component with minimal overlap. Figure 3 .6(C) shows the LV1 loadings which indicate that the main differences between the HC positive cells and HSIL cells are very similar to those found for the HC negative and high grade dyskaryotic samples. Glycogen (482, 1261 and 1381 cm -1 ), nucleic acids (781 cm -1 ), and proteins (1450, 1560 and 1669 cm -1 ) again contribute towards the discrimination. As before, it appears that the overtaking of the host cell machinery by HPV causes more of a biochemical change within the cell than the biochemical changes associated with the use of HC. The predictions plot from the PLS-DA model shows excellent classification of the negative samples (HC positive) and the HSIL cells from high grade dyskaryotic samples ( Kanter et al., 2009) showed that hormonal status influences Raman spectra from the cervix in vivo and that incorporating hormonal status into their classification algorithm increased the accuracy from 88% to 94%. However, the present study and that of (Romeo et al., 2003) on exfoliated cervical cells showed good discrimination between normal and abnormal samples regardless of phase of the menstrual cycle and of whether the woman was taking oral contraceptives or not. 
Conclusion
This study has shown that the day a Pap smear is taken during days 7-21 of the menstrual cycle will have an effect on the spectra with regard to the level of glycogen and proteins. It should be noted, however, that this study assumes that each patient recruited follows the standard 28 day cycle, and that the patient details recorded for each sample were correct. It is possible for women have a longer or shorter cycle, hence this variation may have influenced our analysis. Postmenopausal samples represent a problem for Raman based screening due to their lack of cellular material and presence of cellular debris and mucus. The use of HC causes the most variability. Further study would be required to determine which hormone is causing the discrimination between HC positive and HC negative samples. These findings suggest that the use of oral contraceptives and the day on which the Pap smear was taken during the menstrual cycle should be incorporated into the data analysis to reduce variability between patient samples.
Despite this, however, the variability between days of the menstrual cycle or use of HC did not hinder the ability of Raman spectroscopy to discriminate cytology negative cells from D were more pronounced than the biochemical changes due to the menstrual cycle or the use of hormone based contraceptives. It is acknowledged that the study is limited in focussing only on HSIL positive samples and a further study would be required to include low grade (LSIL) samples. In conclusion, this study highlights the scope of Raman spectroscopy for cervical screening despite the presence of biochemical changes associated with the menstrual cycle and the use of HC.
